How significant is the racial disparity in treating patients with skin cancer? Studies in recent years that suggest a troubling difference in the diagnosis and treatment some patients receive. We explore the significant impact this has on patient prognosis.
The genomic-adjusted radiation dose (GARD) model predicts outcomes of radiotherapy.
Female patients showed an enhanced rate of dermatologic adverse events with immune checkpoint inhibitor therapy for metastatic melanoma.
Researchers studied a total of 1903 cases of pediatric melanoma and patients were 54.4% female, the mean age was 12.4 years, and 89.8% were White.
Researchers studied a total of 1903 cases of pediatric melanoma and patients were 54.4% female, the mean age was 12.4 years, and 89.8% were White.
Combination ipilimumab and nivolumab reduced the risk of death by 56% when compared with fotemustine monotherapy.
More than half of patients responded, and responses deepened over time.
Immune-related adverse events were associated with improved survival outcomes.
PET-CT results led to management changes in 15% of patients.
Rates of relapse-free and overall survival were high as well, exceeding 90%.
